SL
BMY icon

Sentinus LLC’s Bristol-Myers Squibb BMY Stock Holding History

Sentinus LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Sell
27,347
-2,622
-9% -$151K 0.13% 146
2026
Q1 		$1.82M Buy
29,969
+6,522
+28% +$380K 0.16% 120
2025
Q4 		$1.26M Buy
+23,447
New +$1.13M 0.12% 149

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sentinus LLC's BMY Position: Q2 2026 in Review

Sentinus LLC reduced its Bristol-Myers Squibb (BMY) stake by 8.7% in Q2 2026, selling an estimated $151K and leaving 27,347 shares worth $1.58M. The position accounts for 0.13% of the portfolio, ranked #146.

Sentinus LLC first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.82M in Q1 2026. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Sentinus LLC held 27,347 shares of Bristol-Myers Squibb worth $1.58M as of Q2 2026.
  • Sentinus LLC sold 2,622 Bristol-Myers Squibb shares in Q2 2026, an estimated $151K.
  • Bristol-Myers Squibb made up 0.13% of Sentinus LLC's portfolio in Q2 2026, its #146 holding.
  • Sentinus LLC first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Sentinus LLC's Bristol-Myers Squibb position peaked at $1.82M in Q1 2026.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.